Test Price
1,200 AED✅ Home Collection Available
PIK3CA Mutation Analysis in UAE | AED 1200 | DHA Licensed Laboratory
Executive Summary & Core Metrics
This analysis delivers precise detection of somatic PIK3CA gene mutations with 99.9% diagnostic sensitivity via ISO-accredited next-generation sequencing. Designed for oncology precision medicine in the UAE, the service includes secure medical courier solid tissue specimen retrieval from your hospital's pathology department and post-test telephonic clinical guidance.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Logistics: Secure Medical Courier Solid Tissue Specimen Retrieval & Cold-Chain Transport.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance for result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
PIK3CA Mutation Analysis detects somatic mutations in the PIK3CA gene to guide targeted therapy in cancers such as breast, colon, and lung. The assay uses PCR‑enriched next‑generation sequencing covering the full coding region, validated against UAE population variants.
NGS vs. Standard Sanger Sequencing
| Feature | Our Test – PIK3CA Mutation Analysis | Closest Alternative – Standard Sanger Panel |
|---|---|---|
| Precision | Next‑Generation Sequencing (NGS) with >99.9% analytical sensitivity | Sanger sequencing, limited to known hotspots |
| Methodology | PCR‑enriched NGS (full coding region), validated against UAE population variants | PCR + single‑gene Sanger (lower multiplex capacity) |
| Speed | Sample Tuesday by 11 am → Report Monday (6‑day TAT) | Often 10–14 working days |
| Sample Handling | FFPE block, cold‑chain courier transport, NGS Form 40 | In‑clinic deposit, basic documentation |
Physician Insight & Safety Protocols
I understand that receiving a PIK3CA mutation result can feel overwhelming. This analysis helps us pinpoint the exact molecular driver of your cancer, allowing us to tailor a treatment plan that targets the mutation directly and spares you from one‑size‑fits‑all approaches. Please review every result in close coordination with your clinical team.
— Mr. Prabhakar Reddy Kalathoor, Specialist Diagnostic Radiology, DHA ID: 61713011
Critical Contraindications & Safety Alert
- Tissue block with less than 10% tumor cellularity.
- Improperly fixed, non‑formalin‑fixed, or decalcified specimens.
- Missing duly filled NGS Test Requisition Form (Form 40).
- Seek immediate emergency care if you experience acute bleeding, severe pain, or signs of infection at the biopsy site (redness, warmth, fever).
Patient FAQ & Clinical Guidance
What is PIK3CA mutation analysis and why is it ordered?
This test identifies specific genetic alterations in the PIK3CA gene that promote oncogenesis, enabling precise targeted therapy selection for breast, colorectal, and lung cancers.
How is the sample collected for a PIK3CA test?
A certified medical courier retrieves the formalin‑fixed paraffin‑embedded tissue block from your hospital's pathology department via secure cold‑chain logistics. No home phlebotomy is required for this archival solid tissue specimen.
Will my health insurance cover this test in Dubai?
Most UAE insurers cover PIK3CA mutation analysis when pre‑authorized; we verify eligibility directly via WhatsApp +971 54 548 8731.
How long does it take to get the results?
Results are delivered within 6 calendar days from sample submission (Tuesday collection yields a Monday report).
What type of specimen is required for this testing?
A formalin‑fixed paraffin‑embedded (FFPE) tumor tissue block with adequate tumor cellularity (>10%) is mandatory for NGS analysis.
UAE Regulatory & Data Privacy Adherence
This laboratory operates under DHA Facility License No. 1143 and strictly complies with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent protocols adhere to Federal Decree‑Law No. 4 of 2016 on Medical Liability. Certified ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | PIK3CA Mutation Analysis (NGS) |
| Price (AED) | 1,200 AED |
| Turnaround Time | 6 Calendar Days |
| Sample Type / Matrix | Formalin-fixed paraffin-embedded (FFPE) tissue block |
| Methodology Used | PCR-enriched Next-Generation Sequencing (Full Coding Region) |
| ICD-10-CM Code | Z13.89 (Encounter for screening for other specified neoplasm) |
| LOINC Code | 94552-5 (PIK3CA gene mutations found [Identifier] in Tissue or Blood) |
| DHA Facility License & Address | License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians